title: Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
abstract: The proliferation of lymphocytes from HIV-seronegative (HIV Ab-) and seropositive (HIV Ab+) individuals in response to two synthetic peptide epitopes of HIV envelope glycoproteins (ENVgp) was evaluated as an index of cell-mediated immunity in infected individuals. All HIV Ab- and most HIV Ab+ individuals' lymphocytes failed to proliferate in primary cultures in response to the two soluble HIV ENVgp peptides, ENVP346 and ENVP466 even in the presence of rIL-2. After stimulation with liposome-conjugates of ENVP346 or ENVP466 and soluble rIL-2, however, CD4 lymphocytes from some HIV Ab+ individuals were able to proliferate. Significantly higher frequencies of rIL-2-augmented proliferative responses to liposome-conjugated ENVP346 or ENVP466 were observed in HIV Ab+ asymptomatic individuals as compared to patients with AIDS-related conditions or AIDS. These studies indicate that the conjugation of HIV peptides or proteins to liposomes and stimulation with rIL-2 may enhance cell-mediated responses to these peptides.
authors.affiliation: Department of Laboratory Medicine, University of California, San Francisco 94143.
authors.forename: J
authors.initials: J
authors.lastname: Krowka
authors.forename: D
authors.initials: D
authors.lastname: Stites
authors.forename: R
authors.initials: R
authors.lastname: Debs
authors.forename: C
authors.initials: C
authors.lastname: Larsen
authors.forename: J
authors.initials: J
authors.lastname: Fedor
authors.forename: E
authors.initials: E
authors.lastname: Brunette
authors.forename: N
authors.initials: N
authors.lastname: Düzgünes
mesh_terms: D000386:AIDS-Related Complex / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016827:CD8 Antigens; D015686:Gene Products, env / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology; D006679:HIV Seropositivity / Q000276:immunology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D007158:Immunologic Techniques; D066298:In Vitro Techniques; D007376:Interleukin-2 / Q000494:pharmacology; D008081:Liposomes; D008213:Lymphocyte Activation; D012995:Solubility; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D000945:Antigens, Differentiation, T-Lymphocyte; D016827:CD8 Antigens; D015686:Gene Products, env; D007376:Interleukin-2; D008081:Liposomes